News stories about NanoString Technologies (NASDAQ:NSTG) have trended somewhat positive on Sunday, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. NanoString Technologies earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 45.8243265866579 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

NanoString Technologies (NASDAQ NSTG) traded up 1.10% during midday trading on Friday, reaching $15.64. The company’s stock had a trading volume of 194,493 shares. The firm’s market cap is $394.19 million. The firm has a 50 day moving average of $15.03 and a 200 day moving average of $16.94. NanoString Technologies has a 52-week low of $13.17 and a 52-week high of $23.45.

NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings results on Tuesday, August 8th. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.17. The business had revenue of $34.59 million for the quarter, compared to analyst estimates of $29.87 million. NanoString Technologies had a negative return on equity of 329.59% and a negative net margin of 44.28%. Analysts anticipate that NanoString Technologies will post ($2.12) earnings per share for the current fiscal year.

NSTG has been the topic of several research reports. Zacks Investment Research upgraded NanoString Technologies from a “hold” rating to a “buy” rating and set a $19.00 target price on the stock in a research note on Wednesday, July 5th. ValuEngine upgraded NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, July 1st. Cowen and Company restated a “buy” rating on shares of NanoString Technologies in a research note on Friday, July 14th. Finally, BidaskClub cut NanoString Technologies from a “sell” rating to a “strong sell” rating in a research note on Friday, July 28th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $18.50.

COPYRIGHT VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Impact NanoString Technologies (NSTG) Share Price” was posted by Daily Political and is owned by of Daily Political. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Insider Buying and Selling by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with's FREE daily email newsletter.